Zepbound — Revenue
Products & Services · RevenueEli Lilly Zepbound — Revenue increased by 18.7% to $4.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 123.4%, from $1.91B to $4.26B. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2025
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market penetration, successful commercial execution, and growing patient demand for the therapy. A decrease may signal increased competition, supply chain constraints, or loss of market share.
Detailed definition
This metric represents the total gross sales generated from the specific pharmaceutical product line indicated, net of r...
Peer comparison
Comparable to revenue metrics for specific blockbuster drugs or key growth franchises reported by other large-cap pharmaceutical companies.
Metric ID:
lly_segment_zepbound_revenueHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $175.80M | $517.40M | $1.24B | $1.26B | $1.91B | $2.31B | $3.38B | $3.59B | $4.26B |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | — | +194.3% | +140.3% | +1.2% | +51.6% | +21.2% | +46.3% | +6.1% | +18.7% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +984.9% | +346.8% | +172.0% | +185.3% | +123.4% |
Range$0.00 – $4.26B
Avg YoY Growth+362.5%
Median YoY Growth+185.3%
Current Streak8+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's zepbound — revenue?
- Eli Lilly (LLY) reported zepbound — revenue of $4.26B in Q4 2025.
- How has Eli Lilly's zepbound — revenue changed year-over-year?
- Eli Lilly's zepbound — revenue increased by 123.4% year-over-year, from $1.91B to $4.26B.
- What does zepbound — revenue mean?
- The total amount of money earned from sales of a specific drug product.